Non-alcoholic Fatty Liver Disease: all 1,507 studies
Page 1 of 16. Open to participants first (303), then studies with results posted, then the rest; newest registration first within each.
- Chinese Overweight/Obesity Cohort: Metabolic & Comorbidity RisksNot yet recruitingNCT07884903
- DDI Study of ECC0509 With Metformin, Midazolam, and CaffeineNot yet recruitingNCT07873229Phase 1
- Lifestyle, Dietary Patterns, and Cardiometabolic Risk in Metabolic Dysfunction-Associated Steatotic Liver Disease Among People Living With HIVNot yet recruitingNCT07861594
- Trial to Evaluate ALN-CIDEB in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)Not yet recruitingNCT07854782Phase 3
- Nutritional Indices and Inflammatory Markers in MASLDNot yet recruitingNCT07834905
- Misocholic Tablets for Non-Viral Elevated Liver EnzymesNot yet recruitingNCT07833514Phase 3
- Metaboic Syndrome and Fatty Liver in Celiac Disease Females: Reponse to Exercise in AdolescentsRecruitingNCT07832994Not applicable
- Impact of Overt and Subclinical Hypothyroidism on Liver Fibrosis in Patients With MASLDNot yet recruitingNCT07827430
- NMR Metabolomics-Based Risk Assessment and Stratified Digital Health Interventions in Middle-Aged Adults (PREMAP)RecruitingNCT07820800Not applicable
- Body-weight Reduction Effect on Portal Hypertension in Compensated CirrhosisNot yet recruitingNCT07797101Not applicable
- Hypothyroidism and Liver Fibrosis Severity in MASLDNot yet recruitingNCT07793279
- Detecting Liver Fibrosis in Patients At-riskNot yet recruitingNCT07775638
- The Effects of 5-methyltetrahydrofolate Supplementation in Patients With Metabolic Dysfunction-Associated Steatotic Liver DiseaseNot yet recruitingNCT07740109Not applicable
- Non-Invasive Diagnostic Panel for MASLD in Children With ObesityNot yet recruitingNCT07731360
- Study of ECC4703 With Sulfasalazine and PitavastatinRecruitingNCT07726368Phase 1
- Wearable Patch Ultrasound Probe for Diagnosis of Liver StiffnessNot yet recruitingNCT07716384
- Efficacy and Safety of Mazdutide in Patients With Type 2 Diabetes Mellitus and Moderate to Severe Nonalcoholic Fatty Liver Disease Previously Treated With SemaglutideNot yet recruitingNCT07713992Not applicable
- High-intensity Interval Training Versus Moderate Intensity Continuous Training on Gut Microbiota in Non-alcoholic Fatty LiverNot yet recruitingNCT07697313Not applicable
- A Phase III Study to Evaluate the Efficacy and Safety of of DR10624 in Subjects With Severe HypertriglyceridemiaNot yet recruitingNCT07693777Phase 3
- Clinical Course and Biomarkers Associated With Nonalcoholic Fatty Liver Disease (NAFLD) in Chinese Patients With ObesityRecruitingNCT07662356
- Automated Passive Case-Finding for Advanced Liver Fibrosis in MASLD: The LiverSeek ProgrammeRecruitingNCT07658755
- Molecular Characterization of Autoimmune Hepatitis: A Lipidomic ApproachNot yet recruitingNCT07644936
- Linzhi Jianghuang Fufang Huoxue Anshen Capsule for Non-alcoholic Fatty LiverNot yet recruitingNCT07637006Phase 2
- Study to Evaluate ALN-CIDEB in Adults With Fibrotic Metabolic Dysfunction-Associated Steatohepatitis (MASH)Not yet recruitingNCT07631637Phase 2
- Additive Efficacy of Physical Activity Program in Hypthyroidism Elder Females With Glaucoma and Fatty Liver IssuesRecruitingNCT07599241Not applicable
- A Phase 3 Study Evaluating the Safety and Efficacy of HSK31679 in Patients With MASHRecruitingNCT07581951Phase 3
- Efficacy, Safety, and Tolerability of CS0159 Combined With Semaglutide in MAFLD Patients With Obesity and T2DMNot yet recruitingNCT07570810Not applicable
- Impact of Ganoderma Lucidum on NRF2 Levels and Antioxidant Status in Metabolic Asscociated Fatty Liver Disease (GL-MAFLD-NRF2 Study)Enrolling by invitationNCT07564947Not applicable
- A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLDRecruitingNCT07527910Phase 2
- Accurate Point of Care Liver Disease Diagnostics (Phase 2)RecruitingNCT07518784
- Impact of Artificial Intelligence Algorithm-driven Versus Standard Lifestyle Intervention in Non-Alcoholic Fatty Liver Disease - A Multicenter, Randomized, Open-label, Controlled TrialNot yet recruitingNCT07497750Not applicable
- Short and Long Term Clinical and Patient-Reported Outcomes Associated With Intragastric Balloon Placement in Patients With Nonalcoholic Fatty Liver DiseaseEnrolling by invitationNCT07493967
- Tesamorelin for Reduction of Liver Fat in Adults With Fatty Liver Disease (Mock Study)RecruitingNCT07481734Phase 2
- A Randomized, Double-blind, Single-center Phase I/IIa Study of XTYW007 Tablets in Subjects.Not yet recruitingNCT07407634Early Phase 1
- Effect of Insulin Lowering on LipogenesisRecruitingNCT07403604Phase 1
- Duodenal pulsENDO as an Early Treatment for Type 2 DMRecruitingNCT07376486Not applicable
- A Study of Efimosfermin Alfa in Adults With Hepatic ImpairmentRecruitingNCT07358546Phase 1
- ENDOCARE-SCREEN: Metabolic Liver Dysfunction Screening StudyNot yet recruitingNCT07336563
- Thermoacoustic Method for Estimating Liver Fat FractionRecruitingNCT07321925
- Rutin and Vitamin C in Patients With Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)Not yet recruitingNCT07310407Phase 2
- A Trial to Evaluate the Efficacy, Safety, PK, and PD of HP515 in Non - Alcoholic Fatty Liver Disease ( NASH/MASH )RecruitingNCT07308548Phase 2
- A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)RecruitingNCT07288138Phase 2
- Development of a Quantifiable Ultrasound Biomarker for Hepatic SteatosisRecruitingNCT07270601Not applicable
- Using Hydroxychloroquine (HCQ) to Treat SteatohepatitisRecruitingNCT07265297Phase 3
- Validating Integrative Multi-omics Approaches in Metabolic Syndrome-related DiseasesRecruitingNCT07248371
- A Community-based Prospective Cohort Study on Metabolic Dysfunction-Associated Fatty Liver Disease in Older Adults: From Metabolic Trajectories to Extrahepatic OutcomesRecruitingNCT07241195
- iWAIST Trial: ERCG (Endoscopic Radial Compression Gastroplasty) vs Optimized Lifestyle Intervention for Weight LossRecruitingNCT07237750Not applicable
- A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASHRecruitingNCT07221227Phase 3
- A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASHRecruitingNCT07221188Phase 3
- The Improvement Effect of Henggliejin on Fatty Liver in Type 2 Diabetes Patients With Nonalcoholic Fatty Liver:Not yet recruitingNCT07198516Early Phase 1
- Investigation of the Efficacy of a Probiotic Mixture in Moderate Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Mechanistic TrialRecruitingNCT07193927Phase 2
- Empagliflozin Versus Statins in Non-Alcoholic Fatty Liver DiseaseNot yet recruitingNCT07180745Phase 4
- Is There a Relationship Between Uric Acid Level and Liver Fibrosis in Obese PatientsNot yet recruitingNCT07168551
- A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)RecruitingNCT07165028Phase 3
- To Explore the Value of New MR Technology in Non-invasive Quantitative Assessment of Systemic Metabolism, Disease Status and Prognosis in Patients With Metabolic-Associated Fatty Liver DiseaseRecruitingNCT07149571
- Mediterranean Diet in Familial Mediterranean Fever: Is Fatty Liver Affected by Addition of Aerobic ExerciseRecruitingNCT07130318Not applicable
- a Safety, Tolerability, and Pharmacokinetic Trial of Multiple Subcutaneous Injections of B1344 Injection in Patients With Nonalcoholic Fatty Liver Disease（NAFLD）RecruitingNCT07128797Phase 1
- A Safety, Tolerability, Pharmacokinetics/Pharmacodynamics Study of HEC169584 Capsules in Healthy SubjectsRecruitingNCT07099118Phase 1
- The Impact of Pectin Supplementation on Systematic Inflammation Pathway, Gut Microbiome, and Metabolic Health in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)RecruitingNCT07093346Not applicable
- Cardiovascular Risk in Children With Chronic Conditions StudyRecruitingNCT07086989
- Digital Early Warning System for Acute Lung Injury in Liver SurgeryRecruitingNCT07070362
- Gepaktiv vs UDCA and Ademetionine in MAFLD With HepatomegalyRecruitingNCT07068191Not applicable
- Prospective Cohort and Biobank of Patients With Nonalcoholic Fatty Liver DiseaseRecruitingNCT07051863
- The COherence of Scatter Identification and Exclusion Algorithm StudyRecruitingNCT06975579
- Improving Diagnostic Safety Through STeatosis Identification, Risk Stratification, and Referral in the EDEnrolling by invitationNCT06944353Not applicable
- Elucidating Hepatic Metabolism in Non-alcoholic Fatty Liver DiseaseEnrolling by invitationNCT06942312
- An Observational Study of Inflammatory Bowel Disease (IBD) Patients With Non-alcoholic Fatty Liver Disease (NAFLD)RecruitingNCT06939569
- Integrating Metabolic and Vascular Sensors to Monitor Cardiometabolic Disorders After Nutrition InterventionsNot yet recruitingNCT06932289Not applicable
- A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASHRecruitingNCT06920043Phase 2
- Validity of Laboratory Biomarkers in Diagnosis of Nonalcoholic Fatty Liver Disease (NAFLD) and It's ConsequencesNot yet recruitingNCT06908122
- Medium-term Effects of a Polyphenol-rich Beverage Based on Red Grape Pomace Extract on Non-alcoholic Fatty Liver Disease, Cardiometabolic Risk Profile and Gut Microbiota in Subjects with Type 2 DiabetesEnrolling by invitationNCT06895018Not applicable
- OneSTOP (One-Stop Telehealth Obesity Program) for Multidisciplinary Weight Management and Related ComorbiditiesRecruitingNCT06890169Not applicable
- Relationship Between Eating Patterns, Body Composition and the Detection of Fatty Liver in Children and Adolescents With Trisomy 21: LiverTy ProjectEnrolling by invitationNCT06888570
- Secondary and Tertiary Digital Prevention of Non-alcoholic and Dysmetabolic Liver DiseaseRecruitingNCT06879236
- Evaluating the Safety and Efficacy of Carbocisteine in the Treatment of Nonalcoholic Fatty Liver Disease PatientsRecruitingNCT06863376Phase 2
- Human Liver ORganoids as a Model to Study the Development of Non-Alcoholic SteatOhepatitis (NASH)RecruitingNCT06856252Not applicable
- Identification of Liver Fibrosis BiomarkersRecruitingNCT06819917
- Prevalence of Non-Alcoholic Fatty Liver Disease in Inflammatory Bowel Disease PatientsRecruitingNCT06814600
- Pyramidal Versus Continuous Training Effects on Fatty LiverRecruitingNCT06803108Not applicable
- Effect of the Combined Application of Cynara Scolymus, Silybum Marianum, Curcuma Longa, and Glycyrrhiza Glabra in Improving Metabolic Associated Fatty Liver Disease : a Randomized Clinical TrialRecruitingNCT06798948Phase 2
- Characterization and Management of Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)Not yet recruitingNCT06764056Not applicable
- Fatty Liver and Pancreatic SteatosisNot yet recruitingNCT06757348
- The Role of Sugars in Fat Accumulation in the LiverRecruitingNCT06751862Not applicable
- Efficacy of Sodium Glucose Cotransporter 2 Inhibitors on Non-Alcoholic Fatty Liver DiseaseNot yet recruitingNCT06739486
- Thyroid Dysfunction and Its Association With Metabolic Dysfunction-Associated Fatty Liver DiseaseRecruitingNCT06739330
- Feasibility Study of Deep Learning-based MDixon Quant for Quantitative Assessment of Chemotherapy-induced Fatty LiverRecruitingNCT06735118Not applicable
- Assessment of Tolerability of Specialized Food Products Made Out of Vegetable Protein and Their Influence on Lipid Profile in Patients With Non-alcoholic Fatty Liver DiseaseNot yet recruitingNCT06727279Not applicable
- Walking Program in Fatty Liver Children With PhenylketonuriaRecruitingNCT06718842Not applicable
- The Effects of Tai Chi on Metabolic Dysfunction-associated Fatty Liver Disease in Middle-Aged and Older AdultsRecruitingNCT06717828Not applicable
- Establishment of Precise Histological Evaluation Criteria for NASH Fibrosis ReversalRecruitingNCT06707129
- Chrononutrition/ Chronotoxicity Intervention in People With Metabolic-associated Steatotic Liver Disease.Not yet recruitingNCT06705868Not applicable
- Effects of TOTUM-448 on Liver Fat Content, Cardiometabolic Risk Factors and Gut Microbiota Among Participants with MASLDRecruitingNCT06704321Not applicable
- A Phase 1b Study of QX1206 in T2DM Patients With NAFLDRecruitingNCT06694935Phase 1
- Metabolic Associated Fatty Liver Disease in Patients With Chronic Glomerular DiseaseNot yet recruitingNCT06691529
- Effect of Alternate Day Fasting Over Standard Medical Management Alone to Reverse Non-alcoholic Steatohepatitis.RecruitingNCT06676813Not applicable
- NAFLD Clinical Care PathwayRecruitingNCT06671886Not applicable
- Effect of SGLT2 Inhibitors on NAFLD in Type 2 Diabetic Patients with Diabetic NephropathyNot yet recruitingNCT06668753
- Evaluation of a New Ultrasound System for the Non-invasive Assessment of Liver Steatosis in MASLD/MASH PatientsRecruitingNCT06661655Not applicable
- Implementing Food Referrals for Equity and Sustained HealthRecruitingNCT06661538Phase 2
- A Study to Identify the Risk of Non-alcoholic Fatty Liver Disease (NAFLD) in Patients With Type 2 Diabetes in Clinical Practice and to Evaluate the Clinical Usefulness of Dapagliflozin/Pioglitazone Combination TherapyRecruitingNCT06649162